High-Dose Atorvastatin Raises Threshold of Contrast-Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention: A Randomized Controlled Study
Background. Contrast-induced nephropathy (CIN) is a significant complication of angiographic procedures resulting from injection of iodinated contrast media (CM). Patients with diabetes mellitus (DM) are at the highest risk of CIN. Statins have recently been proposed for protection against CIN due t...
Principais autores: | Ahmed Abdel-Galeel, Salma Taha, Khaled M. Elmaghraby, Ramadan Ghaleb, Amr Hanafy, Fabrizio D’Ascenzo, M. Abdelfatah Elsharef, Lobna Abdel-Wahid, Ayman Ibrahim |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Hindawi-Wiley
2021-01-01
|
coleção: | Journal of Interventional Cardiology |
Acesso em linha: | http://dx.doi.org/10.1155/2021/8862316 |
Registros relacionados
-
Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ayman Ibrahim, et al.
Publicado em: (2020-12-01) -
Cardiac effects of direct anti-viral treatment in type II diabetic patients with hepatitis C infection
por: Khaled M. Elmaghraby, et al.
Publicado em: (2024-07-01) -
Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
por: Peyman Bidram, et al.
Publicado em: (2015-01-01) -
Correlation between ankle–brachial index, wall motion score index, and SYNTAX score in acute coronary syndrome patients
por: Abdel-Galeel Ahmed, et al.
Publicado em: (2022-06-01) -
Effects of combined use of atorvastatin and losartan in treating patients with diabetic nephropathy
por: Chao Ding, et al.
Publicado em: (2018-10-01)